3D Printing of Dietary Products for the Management of Inborn Errors of Intermediary Metabolism in Pediatric Populations

3D Printing of Dietary Products for the Management of Inborn Errors of Intermediary Metabolism in Pediatric Populations

The incidence of Inborn Error of Intermediary Metabolism (IEiM) diseases may be low, yet collectively, they impact approximately 6–10% of the global population, primarily affecting children. Precise treatment doses and strict adherence to prescribed diet and pharmacological treatment regimens are im...

Full description

Bibliographic Details
Main Authors: Paola Carou-Senra, Lucía Rodríguez-Pombo, Einés Monteagudo-Vilavedra, Atheer Awad, Carmen Alvarez-Lorenzo, Abdul W. Basit, Alvaro Goyanes, María L. Couce
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Nutrients
Subjects:
chewable formulations and oral drug products
dietary therapy and supplements
intermediary metabolic diseases
extrusion-based three-dimensional printing of personalized pharma-inks
pediatric patients
direct ink writing 3D-printed drug delivery systems
Online Access:https://www.mdpi.com/2072-6643/16/1/61

Internet

https://www.mdpi.com/2072-6643/16/1/61

Similar Items